Stockreport

Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th

Artelo Biosciences, Inc.  (ARTL) 
US:NASDAQ Investor Relations: artelobio.com/investors
PDF SOLANA BEACH, Calif., June 01, 2022 (GLOBE NEWSWIRE) --  Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL), a clinical-stage pharmaceutical company de [Read more]